Current Edition

Blockchain in Life Sciences: Moving From Hype to Adoption

Over the last number of years, along with IOT, AI and Big Data, blockchain has emerged as one of the most significant disrupters in the technical industry. Blockchain’s association with radical technological and business disruption is related to its decentralised nature. The pharmaceutical industry has a vested interest in the future direction of any interoperable platforms that internal/external stakeholders might adopt. Mark McColgan at Almac Group explains that in the world of blockchain, adopting a solid collaboration strategy through your chosen industry can prove to be just as strong a differentiator.